SIGNIFICANT ONGOING CLINICAL TRIALS

Accelerating Clinical Trials of Novel Oncologic PathWays (ACTNOW)

http://www.cancer.gov/aboutnci/recovery/recoveryfunding/actnow

Among the many programs NCI has designated for funding from American Recovery and Reinvestment Act of 2009 is the phase 1-2 clinical trials program ACTNOW (Accelerating Clinical Trials of Novel Oncologic Pathways). It holds great promise for shortening the time it takes to move new cancer therapies from discovery, to development, to approval and safe use by adult and pediatric cancer patients. The program is designed to play a significant role in enabling NCI's goal of developing personalized cancer medicine and an enhanced drug development platform.